These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The role of the microbiome in kidney stone formation. Mehta M; Goldfarb DS; Nazzal L Int J Surg; 2016 Dec; 36(Pt D):607-612. PubMed ID: 27847292 [TBL] [Abstract][Full Text] [Related]
5. Dissolution of calcium oxalate renal stones in patient with jejunoileal bypass and after reanastomosis. Smith CL; Linner JH Urology; 1982 Jan; 19(1):21-3. PubMed ID: 7058580 [No Abstract] [Full Text] [Related]
6. No contribution of ascorbic acid to renal calcium oxalate stones. Gerster H Ann Nutr Metab; 1997; 41(5):269-82. PubMed ID: 9429689 [TBL] [Abstract][Full Text] [Related]
7. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones. Alvarez Arroyo MV; Traba ML; Rapado A Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of kidney stone composition in the detection of metabolic abnormalities. Pak CY; Poindexter JR; Adams-Huet B; Pearle MS Am J Med; 2003 Jul; 115(1):26-32. PubMed ID: 12867231 [TBL] [Abstract][Full Text] [Related]
9. Renal lithiasis in Lebanon: I--the chemical types of urinary calculi. Saksouk FA; Hemady K; Salti IS J Med Liban; 1980; 31(1):81-7. PubMed ID: 16295330 [TBL] [Abstract][Full Text] [Related]
10. Re: Demographics and Characterization of 10,282 Randall Plaque-Related Kidney Stones: A New Epidemic? Assimos DG J Urol; 2015 Aug; 194(2):425. PubMed ID: 26195375 [No Abstract] [Full Text] [Related]
11. Insights into the pathophysiology and treatment of patients with calcium oxalate nephrolithiasis. Assimos DG J Urol; 1998 May; 159(5):1457-8. PubMed ID: 9554332 [No Abstract] [Full Text] [Related]
13. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones. Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278 [TBL] [Abstract][Full Text] [Related]
14. Cystine stones: a single tertiary center experience. Sfoungaristos S; Hakim R; Katz R; Gofrit ON; Landau EH; Yutkin V; Pode D; Duvdevani M J Endourol; 2015 Mar; 29(3):362-6. PubMed ID: 25133928 [TBL] [Abstract][Full Text] [Related]
15. [Composition of 359 kidney stones from the East region of Algeria]. Bouslama S; Boutefnouchet A; Hannache B; Djemil T; Kadi A; Dahdouh A; Saka S; Daudon M Prog Urol; 2016 Jan; 26(1):41-9. PubMed ID: 26531134 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the risk of stone formation: study on crystalluria in patients with recurrent calcium oxalate urolithiasis. Robert M; Boularan AM; Delbos O; Monnier L; Grasset D Eur Urol; 1996; 29(4):456-61. PubMed ID: 8791054 [TBL] [Abstract][Full Text] [Related]